360 related articles for article (PubMed ID: 22399858)
21. Azilsartan medoxomil: a new Angiotensin receptor blocker.
Zaiken K; Cheng JW
Clin Ther; 2011 Nov; 33(11):1577-89. PubMed ID: 22071238
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.
Rakugi H; Enya K; Sugiura K; Ikeda Y
Hypertens Res; 2012 May; 35(5):552-8. PubMed ID: 22278628
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
[TBL] [Abstract][Full Text] [Related]
24. Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.
Miura S; Okabe A; Matsuo Y; Karnik SS; Saku K
Hypertens Res; 2013 Feb; 36(2):134-9. PubMed ID: 23034464
[TBL] [Abstract][Full Text] [Related]
25. The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Satoh M; Haga T; Hosaka M; Obara T; Metoki H; Murakami T; Kikuya M; Inoue R; Asayama K; Mano N; Ohkubo T; Imai Y
J Hypertens; 2016 Jun; 34(6):1218-23. PubMed ID: 27027425
[TBL] [Abstract][Full Text] [Related]
26. Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.
Gitt AK; Bramlage P; Potthoff SA; Baumgart P; Mahfoud F; Buhck H; Ehmen M; Ouarrak T; Senges J; Schmieder RE;
BMC Cardiovasc Disord; 2016 Mar; 16():56. PubMed ID: 26956148
[TBL] [Abstract][Full Text] [Related]
27. Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment.
Dudkowski C; Karim A; Zhao Z; Alonso AB; Garg D; Preston RA
J Clin Pharmacol; 2018 Jan; 58(1):48-56. PubMed ID: 28750149
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.
Wang L; Zhao JW; Liu B; Shi D; Zou Z; Shi XY
Am J Cardiovasc Drugs; 2012 Oct; 12(5):335-44. PubMed ID: 22920046
[TBL] [Abstract][Full Text] [Related]
29. [Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review].
Zakiev VD; Kotovskaya YV; Tkacheva ON
Ter Arkh; 2023 Nov; 95(9):810-817. PubMed ID: 38158926
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
Israili ZH
J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
[TBL] [Abstract][Full Text] [Related]
31. Rationale and Design of the Multicenter Trial on Japan Working Group on the Effects of Angiotensin Receptor Blockers Selection (Azilsartan vs. Candesartan) on Diastolic Function in the Patients Suffering from Heart Failure with Preserved Ejection Fraction: J-TASTE Trial.
Takahama H; Asakura M; Abe Y; Ajioka M; Aonuma K; Anzai T; Hayashi T; Hiramitsu S; Kawai H; Kioka H; Kimura K; Lim YJ; Matsuoka K; Motoki H; Nagata Y; Nakamura S; Ohte N; Ozaki Y; Sasaoka T; Tamaki S; Hamasaki T; Kitakaze M;
Cardiovasc Drugs Ther; 2018 Aug; 32(4):381-388. PubMed ID: 29974299
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
[TBL] [Abstract][Full Text] [Related]
33. Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.
Nishida Y; Takahashi Y; Susa N; Kanou N; Nakayama T; Asai S
Cardiovasc Diabetol; 2013 Nov; 12():159. PubMed ID: 24180232
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis.
Zhao D; Liu H; Dong P
Ir J Med Sci; 2019 May; 188(2):481-488. PubMed ID: 29971568
[TBL] [Abstract][Full Text] [Related]
35. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
36. Azilsartan: a newly approved angiotensin II receptor blocker.
Lam S
Cardiol Rev; 2011; 19(6):300-4. PubMed ID: 21983318
[TBL] [Abstract][Full Text] [Related]
37. Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.
Naruse M; Koike Y; Kamei N; Sakamoto R; Yambe Y; Arimitsu M
PLoS One; 2019; 14(4):e0214727. PubMed ID: 30943275
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.
Shiga Y; Miura SI; Motozato K; Norimatsu K; Yano M; Hitaka Y; Adachi S; Kuwano T; Inoue K; Inoue A; Fujisawa K; Shirotani T; Kusumoto T; Ideishi M; Saku K
Int Heart J; 2017 May; 58(3):416-421. PubMed ID: 28496022
[TBL] [Abstract][Full Text] [Related]
39. Olmesartan compared with other angiotensin II receptor antagonists: head-to-head trials.
Stumpe KO
Clin Ther; 2004; 26 Suppl A():A33-7. PubMed ID: 15291378
[TBL] [Abstract][Full Text] [Related]
40. An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT).
Chazova IE; Zhernakova YV
Curr Med Res Opin; 2021 Feb; 37(2):185-193. PubMed ID: 33119420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
